Markets:

Overview

News

Currencies

International

Treasuries

Cyclerion Therapeutics, Inc. - Common Stock (NQ:CYCN)

1.440 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cyclerion Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket ↗

October 07, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.

Via Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction ↗

October 06, 2022

Via Benzinga

Dow Dips Over 300 Points; Provention Bio Shares Spike Higher ↗

October 06, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 06, 2022

Gainers

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies ↗

June 17, 2022

Via Benzinga

Why Cyclerion Therapeutics Stock Is Getting Hammered ↗

October 06, 2022

Cyclerion Therapeutics Inc (NASDAQ: CYCN) shares are trading lower by 43.33% to $0.53 during Thursday's trading session after the company announced a mitochondrial disease-focused strategy. The plan...

Via Benzinga

Nasdaq Edges Higher; AngioDynamics Shares Plummet ↗

October 06, 2022

U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.

Via Benzinga

Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy

October 06, 2022

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 13, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 01, 2022

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End of The Day Summary ↗

July 28, 2022

Via Benzinga

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate ↗

July 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in Patients with Cognitive Impairment Associated with Schizophrenia (CIAS)

July 28, 2022

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors

July 26, 2022

Renowned neuroscience leader to further long-term clinical research strategy and external collaborations

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 08, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 13, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 13, 2022

Good morning, traders! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

70 Stocks Moving In Monday's Mid-Day Session ↗

June 13, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...

Via Benzinga

30 Stocks Moving in Monday's Pre-Market Session ↗

June 13, 2022

Gainers G Medical Innovations Holdings Ltd (NASDAQ: GMVD) rose 53.6% to $0.5301 in pre-market trading after dropping more than 28% on Friday.

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

44 Stocks Moving In Friday's Mid-Day Session ↗

June 10, 2022

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 10, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 08, 2022

Gainers

Via Benzinga

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.